Index

ALS. See amyotrophic lateral sclerosis (ALS) ALT. See alanine aminotransferase (ALT) Alternate Healthy Eating Index 2010 (AHEI- 2010), 4

alternative medicine. See complementary and alternative medicine (CAM) aluminum binders, 172 Alzheimer’s disease, 7, 9, 85, 120, 151, 155, 276 ambulatory care centers, 27

ambulatory care-sensitive diagnoses (ACSDs), 287

American Cancer Society, 187 American Diabetes Association, 177 American Institute for Cancer Research/World Cancer Research Fund (AICR/WCRF), 186, 187 American Medical Directors Association (AMDA), 32

dehydration guidelines, 125–126 American Red Cross, 361 American Indian, 105, 176 Alaska Native, 176

American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), 255, 259 amino acids. See protein amoxicillin, 166 amputation, 80–81

amylin agonist pramlintide, 185

amyotrophic lateral sclerosis (ALS), 155, 269 analgesics, 9, 236, 238, 249 ANDHII. See Academy of Nutrition and Dietetics, Health Informatics Infrastructure (ANDHII) anemia, 83, 159–168, 187, 199, 220, 222, 223, 224, 228, 229

in chronic kidney disease, 171, 172 classifications, 160–161 etiologies of, 83, 159 implications for practice, 164

lab tests, 161, 162, 163, 164, 166–167, 168, 216, 217

medications, 166–167

anemia of chronic disease, 83, 159, 161, 162–163, 168, 172, 222–223 ano-rectum, 5

anorexia, 6, 7, 77, 84, 86, 107, 108, 111–112, 273, 274, 275. See also weight loss cancer and, 187, 190, 191, 195 drugs associated with, 6, 7, 77 medications, 112–113

antacids/acid blockers, 164, 166, 246, 173, 250

385

anthropometrics, 53, 56, 58, 60, 62, 64, 74, 77– 78, 80, 81, 109, 113, 253 antibiotics, 7, 111, 148, 166, 223, 225, 226, 228, 238, 246

antibiotic therapy, 26, 62, 260 anticholinergic effects. See medications, side effects

anticoagulants, 219, 238, 239, 246, 248 anticoagulation therapy, 261 anticonvulsants, 7, 111, 166–167, 239, 246 antidiabetics, 246 antiepileptics, 6, 148 antihistamines, 7, 9, 85, 111, 238, 246 antihyperlipidemics, 239, 247

antihypertensives, 149, 218, 236, 239, 241, 247 antineoplastics, 111, 166, 188, 189, 223, 225, 247 antioxidants, 9 aphasia, 44

appetite, 4, 6, 8, 42, 74, 108–109, 110, 113, 195, 234, 268, 274

appetite stimulants, 121–113, 120–121 apraxia, 44 ARD. See Assessment Reference Date (ARD) AREDS2. See Age-Related Eye Disease Study 2 (AREDS2)

ascites, 75, 79, 85, 225, 226, 227, 259 ascorbic acid, 7, 148, 229, 248 drug interactions, 248

aspartate aminotransferase (AST), 216, 218, 263 aspiration, 40, 46, 134, 148, 149, 150, 151, 152, 194, 256, 259–260, 273, 275, 276, 281 aspirin, 83, 148, 166, 216, 218, 219, 223, 225, 228, 229, 237, 246, 249

Assessment Reference Date (ARD), 305, 311 Asian American, 104–105, 176 Japanese American, 105 Korean American, 105 Vietnamese American, 105 assisted living, 25, 27, 77, 337, 346 atherosclerosis, 228 atrial natriuretic factor, 124 Axid, 246

azotemia, 220, 225, 260

barbiturates, 166, 220, 237, 246, 250 basal energy expenditure (BEE), 82, 96, 97 bed-bound client, 46 Beers criteria, 233–234 belching, 282